Arcutis Biotherapeutics, Inc. (ARQT)
29.79
+0.03
(+0.10%)
USD |
NASDAQ |
Dec 10, 16:00
29.85
+0.06
(+0.20%)
After-Hours: 17:40
Arcutis Biotherapeutics Total Liabilities (Quarterly): 212.90M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 137.50M |
| ANI Pharmaceuticals, Inc. | 902.34M |
| CorMedix, Inc. | 376.73M |
| Editas Medicine, Inc. | 188.30M |
| Syndax Pharmaceuticals, Inc. | 436.36M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 370.98M |
| Shareholders Equity (Quarterly) | 158.07M |
| Debt to Equity Ratio | 0.7198 |
| Current Ratio | 3.500 |
| Net Debt Paydown Yield | 0.83% |